Suppr超能文献

莫尔-特拉内伯格综合征的耳病理学

Otopathology in Mohr-Tranebjaerg syndrome.

作者信息

Bahmad Fayez, Merchant Saumil N, Nadol Joseph B, Tranebjaerg Lisbth

机构信息

Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114-3096, USA.

出版信息

Laryngoscope. 2007 Jul;117(7):1202-8. doi: 10.1097/MLG.0b013e3180581944.

Abstract

BACKGROUND

Mohr-Tranebjaerg syndrome (MTS) is an X-linked, recessive, syndromic sensorineural hearing loss (HL) characterized by onset of deafness in childhood followed later in adult life by progressive neural degeneration affecting the brain and optic nerves. MTS is caused by mutations in the DDP/TIMM8A gene, which encodes for a 97 amino acid polypeptide; this polypeptide is a translocase of the inner mitochondrial membrane.

OBJECTIVES

To describe the otologic presentation and temporal bone histopathology in four affected individuals with MTS.

MATERIAL AND METHODS

All four subjects belonged to a large, multigenerational Norwegian family and were known to carry a frame shift mutation in the TIMM8A gene. Temporal bones were removed at autopsy and studied by light microscopy. Cytocochleograms were constructed for hair cells, stria vascularis, and cochlear neuronal cells. Vestibular neurons were also counted.

RESULTS

All four subjects developed progressive HL in early childhood, becoming profoundly deaf by the age of 10 years. All four developed language, and at least one subject used amplification in early life. Audiometric evaluation in two subjects showed 80- to 100-dB HL by the age of 10 years. The subjects died between the ages of 49 and 67. The otopathology was strikingly similar in that all bones examined showed near-total loss of cochlear neuronal cells and severe loss of vestibular neurons. When compared with age-matched controls, there was 90% to 95% loss of cochlear neurons and 75% to 85% loss of vestibular neurons.

CONCLUSIONS

We infer that the HL in MTS is likely to be the result of a postnatal and progressive degeneration of cochlear neurons and that MTS constitutes a true auditory neuropathy. Our findings have implications for clinical diagnosis of patients with MTS and management of the HL.

摘要

背景

莫尔-特拉内耶尔格综合征(MTS)是一种X连锁隐性综合征性感音神经性听力损失(HL),其特征为儿童期开始出现耳聋,成年后逐渐出现影响大脑和视神经的进行性神经变性。MTS由DDP/TIMM8A基因突变引起,该基因编码一种97个氨基酸的多肽;这种多肽是线粒体内膜转位酶。

目的

描述4例MTS患者的耳科表现及颞骨组织病理学特征。

材料与方法

所有4例受试者均来自一个大型多代挪威家族,已知携带TIMM8A基因的移码突变。尸体解剖时取出颞骨,进行光镜检查。构建毛细胞、血管纹和耳蜗神经细胞的细胞耳蜗图。还对前庭神经元进行计数。

结果

所有4例受试者在幼儿期均出现进行性HL,10岁时完全失聪。所有4例受试者均学会了语言,至少1例受试者在早年使用了助听器。2例受试者的听力测试评估显示,10岁时听力损失为80至100分贝。受试者于49至67岁之间死亡。耳病理学表现惊人地相似,所有检查的颞骨均显示耳蜗神经细胞几乎完全丧失,前庭神经元严重丧失。与年龄匹配的对照组相比,耳蜗神经元丧失90%至95%,前庭神经元丧失75%至85%。

结论

我们推断MTS中的HL可能是耳蜗神经元出生后进行性变性的结果,且MTS构成一种真正的听觉神经病。我们的研究结果对MTS患者的临床诊断和HL的治疗具有重要意义。

相似文献

1
Otopathology in Mohr-Tranebjaerg syndrome.
Laryngoscope. 2007 Jul;117(7):1202-8. doi: 10.1097/MLG.0b013e3180581944.
2
Temporal bone histopathologic and genetic studies in Mohr-Tranebjaerg syndrome (DFN-1).
Otol Neurotol. 2001 Jul;22(4):506-11. doi: 10.1097/00129492-200107000-00017.
4
Histopathology of nonsyndromic autosomal dominant midfrequency sensorineural hearing loss.
Otol Neurotol. 2008 Aug;29(5):601-6. doi: 10.1097/MAO.0b013e3181778245.
6
Temporal bone histopathology in alport syndrome.
Laryngoscope. 2004 Sep;114(9):1609-18. doi: 10.1097/00005537-200409000-00020.
8
Otopathology in congenital toxoplasmosis.
Otol Neurotol. 2013 Aug;34(6):1165-9. doi: 10.1097/MAO.0b013e31828297b6.
10
Cochlear and retinal degeneration in the tubby mouse.
Neuroreport. 1995 Apr 19;6(6):845-9. doi: 10.1097/00001756-199504190-00005.

引用本文的文献

3
A novel therapeutic pathway to the human cochlear nerve.
Sci Rep. 2024 Nov 5;14(1):26795. doi: 10.1038/s41598-024-74661-5.
4
Brazilian Society of Otology task force - cochlear implant ‒ recommendations based on strength of evidence.
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101512. doi: 10.1016/j.bjorl.2024.101512. Epub 2024 Sep 16.
5
The Role and Research Progress of Mitochondria in Sensorineural Hearing Loss.
Mol Neurobiol. 2025 Jun;62(6):6913-6921. doi: 10.1007/s12035-024-04470-4. Epub 2024 Sep 18.
6
Outcomes of cochlear implantation in 75 patients with auditory neuropathy.
Front Neurosci. 2023 Nov 13;17:1281884. doi: 10.3389/fnins.2023.1281884. eCollection 2023.
7
Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder.
J Clin Med. 2023 Jan 17;12(3):738. doi: 10.3390/jcm12030738.
8
Electrocochleography in Auditory Neuropathy Related to Mutations in the OTOF or OPA1 Gene.
Audiol Res. 2021 Nov 26;11(4):639-652. doi: 10.3390/audiolres11040059.
9
Is auditory neuropathy an appropriate term? A systematic literature review on its aetiology and pathogenesis.
Acta Otorhinolaryngol Ital. 2021 Dec;41(6):496-506. doi: 10.14639/0392-100X-N0932. Epub 2021 Nov 26.
10
Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy.
Neural Plast. 2020 Aug 28;2020:8843485. doi: 10.1155/2020/8843485. eCollection 2020.

本文引用的文献

1
Multichannel cochlear implants: relation of histopathology to performance.
Laryngoscope. 2006 Aug;116(8):1310-20. doi: 10.1097/01.mlg.0000227176.09500.28.
3
The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a-TIMM13 complex.
Hum Mol Genet. 2004 Sep 15;13(18):2101-11. doi: 10.1093/hmg/ddh217. Epub 2004 Jul 14.
4
Sex-linked deafness of a possibly new type.
Acta Genet Stat Med. 1960;10:54-62. doi: 10.1159/000151118.
6
"Auditory neuropathy": physiologic and pathologic evidence calls for more diagnostic specificity.
Int J Pediatr Otorhinolaryngol. 2003 Jul;67(7):707-28. doi: 10.1016/s0165-5876(03)00103-4.
7
Outcome of cochlear implantation in pediatric auditory neuropathy.
Otol Neurotol. 2002 May;23(3):328-32. doi: 10.1097/00129492-200205000-00017.
8
Pediatric cochlear implantation in auditory neuropathy.
Otol Neurotol. 2002 Mar;23(2):163-8. doi: 10.1097/00129492-200203000-00011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验